Variant report
Variant | esv1819979 |
---|---|
Chromosome Location | chr7:109409755-109455926 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:109452833..109454349-chr7:109467899..109470407,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs145227378 | chr7:109409765-109409766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs190386787 | chr7:109409792-109409793 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs552943657 | chr7:109409830-109409831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs528705229 | chr7:109409833-109409834 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs10231833 | chr7:109409859-109409860 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs541423851 | chr7:109409878-109409879 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs74473588 | chr7:109409889-109409890 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs575342099 | chr7:109409904-109409905 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs544323310 | chr7:109409954-109409955 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs180868636 | chr7:109409959-109409960 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs376351584 | chr7:109410013-109410014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs35999190 | chr7:109410084-109410085 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs532340068 | chr7:109410122-109410123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs148457029 | chr7:109410163-109410164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs144095841 | chr7:109410164-109410165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs188480188 | chr7:109410180-109410181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs370727145 | chr7:109410187-109410188 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs200154160 | chr7:109410285-109410286 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs528474573 | chr7:109410296-109410297 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs575716315 | chr7:109410297-109410298 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs570121303 | chr7:109410304-109410305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs531144425 | chr7:109410305-109410306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs181280167 | chr7:109410306-109410307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs141099697 | chr7:109410404-109410405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs550723955 | chr7:109410462-109410463 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs144853196 | chr7:109410472-109410473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs371321305 | chr7:109410473-109410474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs151147051 | chr7:109410479-109410480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs555425082 | chr7:109410480-109410481 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs140050131 | chr7:109410521-109410522 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs568120447 | chr7:109410555-109410556 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs544236672 | chr7:109410622-109410623 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs185565662 | chr7:109410624-109410625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs577835204 | chr7:109410644-109410645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs546046069 | chr7:109410648-109410649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs373239189 | chr7:109410707-109410708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs569261814 | chr7:109410722-109410723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs73191835 | chr7:109410828-109410829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs182917444 | chr7:109410908-109410909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs187202507 | chr7:109410925-109410926 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs562051642 | chr7:109410947-109410948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs530764652 | chr7:109410948-109410949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs550581396 | chr7:109410959-109410960 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs570574504 | chr7:109410961-109410962 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs386716767 | chr7:109410973-109410974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs533233236 | chr7:109410994-109410995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs373883457 | chr7:109411080-109411081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs368084996 | chr7:109411093-109411094 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs536141172 | chr7:109411138-109411139 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs150324360 | chr7:109411154-109411155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Breast cancer | 16397240 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Autism | 19401682 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
small cell lung cancer | 20016488 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:109408800-109410400 | Weak transcription | Dnd41 | blood |
2 | chr7:109410400-109410800 | Enhancers | Dnd41 | blood |
3 | chr7:109410800-109412400 | Weak transcription | Dnd41 | blood |
4 | chr7:109412200-109412800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
5 | chr7:109412400-109412600 | Enhancers | Dnd41 | blood |
6 | chr7:109412400-109412800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
7 | chr7:109412400-109413200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr7:109415600-109416800 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr7:109419400-109419600 | Enhancers | Dnd41 | blood |
10 | chr7:109419600-109420600 | Weak transcription | Dnd41 | blood |
11 | chr7:109420600-109422600 | Enhancers | Dnd41 | blood |
12 | chr7:109422600-109422800 | Flanking Active TSS | Dnd41 | blood |
13 | chr7:109422800-109423000 | Enhancers | Dnd41 | blood |
14 | chr7:109423000-109423200 | Flanking Active TSS | Dnd41 | blood |
15 | chr7:109423200-109425600 | Enhancers | Dnd41 | blood |
16 | chr7:109434600-109435200 | ZNF genes & repeats | Dnd41 | blood |
17 | chr7:109435000-109435400 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
18 | chr7:109435200-109435800 | Weak transcription | Dnd41 | blood |
19 | chr7:109435800-109436000 | Enhancers | Dnd41 | blood |